Aidoc
Clinical AI platform for radiology and enterprise imaging workflows.
Last updated: June 5, 2026
Back to directoryMedical imaging AI platform used for disease detection and care pathways.
Organizations evaluating imaging AI for public health, lung cancer, TB, and emergency workflows.
Compare within workflow: Medical imaging and radiology · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Qure.ai as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Separate each Qure.ai product and regional deployment because chest X-ray, CT, TB, lung-nodule, and stroke workflows may have different authorization status. |
|---|---|
| Privacy | Review image routing, cloud or local deployment, de-identification before cloud processing, retention, public-health data sharing, DICOM metadata handling, and cross-border processing terms. |
| Evidence | Validate performance for the target population, prevalence, scanner mix, and clinical pathway, especially when moving from public-health screening into hospital care. |
| Workflow | Best evaluated with radiologist or clinician review, escalation rules, and equity monitoring for false positives and false negatives across deployment sites. |
Qure.ai describes medical imaging AI for tuberculosis, lung cancer, stroke, and other care pathways; its regulatory and privacy page lists product-specific U.S. FDA 510(k) clearances, CE certifications, ISO 27001 status, de-identification, and deployment-security controls.
Not for: Unsupervised imaging interpretation or use outside specific product intended uses.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.